Processa Pharmaceuticals Inc (PCSA)

Jan 07, 2026

Processa Pharmaceuticals Regains Nasdaq Minimum Bid Compliance - TipRanks

Jan 07, 2026

Jan 06, 2026

Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Pal-Item

Jan 06, 2026

Jan 06, 2026

Processa Pharmaceuticals completes enrollment for NGC-Cap breast cancer study - Investing.com Nigeria

Jan 06, 2026

Jan 05, 2026

Processa Pharmaceuticals completes enrollment of 20th patient in Phase 2 study - TipRanks

Jan 05, 2026

Jan 05, 2026

Processa Pharmaceuticals (PCSA) Advances in Phase 2 Cancer Study - GuruFocus

Jan 05, 2026

Jan 05, 2026

Processa Pharmaceuticals completes enrollment for NGC-Cap breast cancer study By Investing.com - Investing.com South Africa

Jan 05, 2026

Jan 05, 2026

Processa Pharmaceuticals Completes Patient Enrollment for Phase 2 Clinical Study of NGC-Cap in Advanced Breast Cancer, Interim Data Expected Q1 2026 - Quiver Quantitative

Jan 05, 2026

Jan 05, 2026

Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study - The Manila Times

Jan 05, 2026

Jan 05, 2026

New combo cancer drug reaches key test in advanced breast cancer trial - Stock Titan

Jan 05, 2026

Jan 01, 2026

Processa Pharmaceuticals Inc. (PCSA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jan 01, 2026

Dec 30, 2025

User | chroniclejournal.comProcessa Pharmaceuticals, Inc.Common Stock (Nasdaq:PCSA) Stock Quote - FinancialContent

Dec 30, 2025

Dec 29, 2025

Why did Processa Pharmaceuticals stock surge 160% today? - MSN

Dec 29, 2025

Dec 26, 2025

Oracle, Hut 8, Processa Pharmaceuticals, Recursion Pharmaceuticals, Udemy: Stocks making the biggest moves today - MSN

Dec 26, 2025